Merck & Co

Ticker Symbol: MRK Exchange: NYSE

Company Profile

Merck & Co. develops, manufactures and markets a broad variety of vaccines, prescription products, consumer products and animal health products worldwide. The company generates more than 55% of its annual revenues outside of the U.S. with almost 27% coming from Europe, the Middle East and Africa. Merck's R&D is focused on diseases such as Alzheimer's, diabetes and cancer. MRK shares are a component of both the S&P 500 and the Dow Jones Industrial Average.

Key Products & Services:
Claritin, Coppertone, Dr. Scholl's, Lotrimin, Gardasil, Pepcid, Cipro, Clarinex, Singulair, Propecia

Target Investor:
Style:   What's this?
Risk:

Key Statistics* 2005 2006 2007 2008 2009 2010
Revenue ($ millions) $22,011.9 $22,636.0 $24,197.7 $23,850.3 $27,428.3 $45,987.0
EPS $2.10 $2.03 $1.49 $3.64 $5.65 $0.28
Dividend $1.52 $1.52 $1.52 $1.52 $1.52 $1.52

* Acquired Schering-Plough in 2010


DRIP Plan Summary:
Shares Needed to Qualify: 1
Minimum Additional Investment: $50
Maximum Additional Investment: $50,000/year
Additional Purchase Discount: None
Purchase Trading Fee: $5 plus $0.01/share (by check)
$2 plus $0.01/share (by one-time automatic withdrawal)
Dividend Reinvestment Trading Fee: Company paid
Dividend Reinvestment Service Fee: 4%, maximum = $2

Plan Prospectus

Investor Contact Information:
Transfer Agent: Wells Fargo Shareowner Services
Mail: Shareowner Relations Department
P.O. Box 64854
St. Paul, MN 55164
Phone: 800-522-9114
IR website: http://merck.com/investors/home.html?WT.svl=topnav


* By clicking this button you will initiate a share purchase request to other FirstShare community members.

Advertisement